European stocks are likely to start positive as AstraZeneca's COVID-19 vaccine has been approved for emergency supply in the UK, despite mixed Asian performance and the negative cues from Wall Street amid uncertainty about whether the U.S. Senate would approve planned increase in stimulus checks.
The UK Medicines and Healthcare products Regulatory Agency has approved AstraZeneca's COVID-19 vaccine for emergency supply in the UK, with the first doses being released today. The vaccinations may begin early in the New Year.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com